Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Cancer Epidemiol. 2024 Feb;88:102519. doi: 10.1016/j.canep.2023.102519. Epub 2024 Jan 5.
Comparing cancer mortality and associated risk factors among immigrant populations in a host country to those in their country of origin reveals disparities in cancer risk, access to care, diagnosis, and disease management. This study compares cancer mortality between the German resident population and Germany-born individuals who migrated to the US.
Cancer mortality data from 2008-2018 were derived for Germans from the World Health Organization database and for Germany-born Americans resident in four states (California, Florida, Massachusetts, and New York) from respective Departments of Vital Statistics. We calculated age-standardized mortality rates (ASMRs) using the European standard population and standardized mortality ratios (SMR) compared to the German resident population along with 95% confidence intervals (CIs).
Germany-born American males had lower ASMRs (253.8 per 100,000) than German resident population (325.6 per 100,000). The difference in females was modest, with ASMRs of 200.7 and 203.7 per 100,000, respectively. For all cancers, Germany-born American males had an SMR of 0.72 (95% CI: 0.70-0.74) and females 0.98 (95% CI: 0.95-1.00). Male SMRs among Germany-born Americans were significantly below one for oral cavity, stomach, colorectal, liver, lung, prostate, and kidney cancer. Among females, SMRs were below one for oral cavity, stomach, colorectal, gallbladder, breast, cervix uteri, and kidney cancer. For both sexes, SMRs were over one for bladder cancer (1.14 for males, 1.21 for females). Mortality was higher for lung cancer (SMR: 1.68), non-Hodgkin's lymphoma (1.18) and uterine cancer (1.22) among Germany-born American females compared to the German resident population.
Germany-born American males but not females showed lower cancer mortality than German resident population. Disparities may stem from variations in risk factors (e.g., smoking and alcohol use) as well as differences in screening practices and participation, cancer treatment, besides some residual potential "healthy immigrant effect".
比较移民国家的移民人口与原籍国的癌症死亡率和相关风险因素,可以揭示癌症风险、医疗保健获取、诊断和疾病管理方面的差异。本研究比较了德国居民人口与移居美国的德国出生人群的癌症死亡率。
从世界卫生组织数据库中获取了 2008 年至 2018 年德国人的癌症死亡率数据,以及居住在加利福尼亚州、佛罗里达州、马萨诸塞州和纽约州的德国出生美国人的死亡率数据,这些数据分别来自各自的州立生命统计部门。我们使用欧洲标准人口计算了年龄标准化死亡率(ASMR),并使用标准化死亡率比(SMR)与德国居民人口进行了比较,同时还给出了 95%置信区间(CI)。
与德国居民人口(每 10 万人 325.6 人)相比,移居美国的德国男性的 ASMR 较低(每 10 万人 253.8 人)。女性的差异较小,ASMR 分别为每 10 万人 200.7 和 203.7 人。对于所有癌症,移居美国的德国男性的 SMR 为 0.72(95%CI:0.70-0.74),女性为 0.98(95%CI:0.95-1.00)。移居美国的德国男性的 SMR 显著低于口腔癌、胃癌、结直肠癌、肝癌、肺癌、前列腺癌和肾癌。对于女性,口腔癌、胃癌、结直肠癌、胆囊癌、乳腺癌、宫颈癌和肾癌的 SMR 均低于 1。对于两性,膀胱癌的 SMR 均高于 1(男性为 1.14,女性为 1.21)。与德国居民人口相比,移居美国的德国女性的肺癌(SMR:1.68)、非霍奇金淋巴瘤(1.18)和子宫癌(1.22)的死亡率更高。
与德国居民人口相比,移居美国的德国男性而非女性的癌症死亡率较低。差异可能源于风险因素的差异(如吸烟和饮酒)以及筛查实践和参与、癌症治疗的差异,此外还可能存在一些残余的“健康移民效应”。